Heartwatch: an Irish cardiovascular secondary prevention programme in primary care, a secondary analysis of patient outcomes
Open Access
Abstract
Objectives To investigate patient follow-up data from Heartwatch: Ireland’s secondary prevention programme for cardiovascular disease delivered in general practice. Design Retrospective descriptive study based on secondary analysis of routinely collected data from Heartwatch. Setting Heartwatch targeted 20% of general practices in Ireland and recruited 475 general practitioners across 325 practices. Participants The patient population included people with a history of acute myocardial infarction, percutaneous transluminal coronary angioplasty or a coronary artery bypass graft. Over 16 000 patients entered the programme however, to assess the long-term progress of patients, we identified a cohort of 5700 patients with at least 8 years in the programme. Interventions A standard protocol for continuing care of patients for the secondary prevention of cardiovascular disease was administered by general practices. The programme was designed using WHO and European Society of Cardiology guidelines on secondary prevention. Outcome measures A Continuing Care (CCare) score out of eight was the primary outcome measure used. It was calculated based on programme targets for well-known cardiovascular risk factors: exercise, systolic blood pressure, LDL cholesterol, optimally controlled glucose, smoking status, and pharmacological treatment. Results After 1 year, 37% of the 8-year cohort had achieved a CCare score >5 increasing to 44% after year 8. Patient sex was predictive of better scores; male patients had almost a half-point advantage (0.432, 99% CI: 0.335 to 0.509). Patients who enrolled earlier following their qualifying event and patients with more frequent visits were also more likely to achieve higher CCare scores. Conclusions Overall, patients are not likely to meet all targets set by secondary prevention guidelines, however, supporting patient self-management may impact on this. Early enrolment after a cardiac event and frequent structured care visits should be priorities in the design and implementation of similar programmes. Ongoing evaluation of them is necessary to improve outcomes.Keywords
This publication has 37 references indexed in Scilit:
- Secondary prevention after acute myocardial infarction: Drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 RegistryEuropean Journal of Preventive Cardiology, 2014
- Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized TrialsJACC, 2013
- Primary Care Equals Secondary Prevention in Ischemic Heart DiseaseJournal of General Internal Medicine, 2011
- Heartwatch: the effect of a primary care-delivered secondary prevention programme for cardiovascular disease on medication use and risk factor profilesEuropean Journal of Preventive Cardiology, 2010
- EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countriesEuropean Journal of Preventive Cardiology, 2009
- Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studiesBMJ, 2007
- Survival-related biases survive wellInternational Journal of Epidemiology, 2006
- Effectiveness of Statin Therapy in Adults With Coronary Heart DiseaseArchives of internal medicine (1960), 2004
- The way I see it: House officers need formal career developmentBMJ, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002